Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin alfa vs placebo in mechanically ventilated trauma ICU patients
2020-003388-24Phase 3Active
- Sponsor
- University College Dublin
- Start
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Physical trauma comparing Epoetin alfa (Binocrit) with Placebo (2 arms). Primary endpoint: Mortality and severe disability at 6 months. Started Oct 2020; status: active.
02
Drugs
epoetin alfa
03
Conditions
Physical trauma
Beyond the preview
Go deeper on 2020-003388-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003388-24.